How Google Is taking Pole Position.
Alphabet Inc. companies Verily and Deep Mind: Steering Google’s Drive Towards Pioneering AI-Driven Healthcare Innovations
The AI Healthcare market is projected to reach $19.25 billion by 2026 and could progress to be over 80B$ by 2030 with an estimated CAGR ranging from 37% to 43.83%. Google Verily and DeepMind‘s AI-enabled medical technologies position them exceptionally well to capture a significant portion of this rapidly growing market.
Google has been investing heavily in healthcare, life sciences, and medical technologies domains, developing products and solutions through Google Verily and Google DeepMind. Artificial intelligence (AI) is poised to revolutionize the healthcare industry, and Google’s subsidiaries Verily and DeepMind are leading the charge with their AI-powered healthcare innovations. By harnessing the capabilities of AI,ML and generative AI tools, coupled with Cloud Computing and ever improving Data Analytics capabilities, Verily has developed cutting-edge healthcare technology and life sciences solutions. DeepMind, on the other hand, focuses on AI-driven approach for research and development to pioneer medical technologies. In this article we try and explores the latest AI-driven advancements by Google via Verily and DeepMind, highlights of their business potential and scientific impact, and try and decipher Google’s playbook in AI lead healthcare Technology Solutions.
Verily and DeepMind, both subsidiaries of tech titan Alphabet Inc. along with Google, are catalyst of AI transformation. Their remarkable advancements in medical technology and life sciences solutions, fueled by AI, ML, and generative AI tools, are not only reshaping the landscape but also redefining how healthcare is approached from research and development to sales and customer relationship management.
Unfolding How Google AI is Revolutionizing Healthcare Sectors
Google’s path to becoming a leader in AI-enabled medical technologies began with the establishment of Google Health in 2008. Following its branding as Verily, Google continued its AI research and development journey with the inception of DeepMind in 2010. DeepMind focused on creating AI algorithms capable of learning from vast datasets. The entwined journey of Google’s AI and healthcare innovation fast tracked in 2016, when DeepMind showcased the power of AI in diagnosing diseases from medical images with unprecedented precision. This breakthrough moment marked the onset of a series of groundbreaking projects that have since propelled the evolution of healthcare AI. The flagship Project Baseline exemplifies Verily’s visionary approach — collecting exhaustive health data from a diverse populace to unlock profound insights into human health and unearth novel disease patterns.
Google Verily, working on its way to becoming a prominent player in life sciences, has embarked on a transformative path by adopting a holistic healthcare innovation strategy. With AI, ML, and generative AI tools at its core, Verily is driving diverse initiatives that span
- Disease detection,
- Wearable Connected Tech
- Patient monitoring, and
- Drug Development.
Verily’s Study Watch is a wearable device that employs ML to collect and analyze real-time health data. Designed to monitor vital statistics such as pulse rate, respiration rate, and electro-dermal activity, Study Watch holds great promise for disease intervention, particularly for patients with conditions such as Parkinson’s disease. The company has launched several patient-facing technology tools such as the Onduo digital health platform for chronic disease management.
Verily received a $1 billion investment in 2021 to fund its business strategies that are additive and complementary to its current life sciences portfolio. The company has made senior executive appointments and at the same time eliminated approx. 200+ jobs, accounting for 15% of the workforce in a bid to Automate with AI.
FMCG and Wellness play – Verily’s collaboration with L’Oreal to launch a multi-year study that will help researchers better understand biological, clinical, and environmental factors that contribute to skin and hair health over time exemplifies the company’s commitment to precision health. The study aims to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle, environment, wellness, and personal beauty routines.
DeepMind’s Major Leap Forward
Across the spectrum, Google DeepMind has unveiled an array of medical breakthroughs that underscore AI’s immense potential in healthcare. From accurately identifying eye diseases through retinal scans to predicting patient deterioration using clinical data streams, DeepMind’s AI algorithms are shaping up to not only enhance diagnostics but also refine patient care strategies. Google Cloud is committed to bringing to market products that are informed by our research efforts across Alphabet. In 2022, they introduced a deep integration between Google Cloud and Alphabet’s AI research organizations, which allows Vertex AI to run DeepMind’s groundbreaking protein structure prediction system, AlphaFold.
The recently announced Claims Acceleration Suite helps both providers of insurance plans and healthcare to create operational efficiencies and reduce administrative burdens and costs by converting unstructured data into structured data that help experts make faster decisions and improve access to timely patient care.
Imaging Sciences Solutions – On the Imaging technology side Medical Imaging Suite, an AI-assisted diagnosis technology is being used by Hologic to improve cervical cancer diagnoses and Hackensack Meridian Health to predict metastasis in patients with prostate cancer. Elsewhere, Mayo Clinic and Google have collaborated on an AI algorithm to improve the care of head and neck cancers, and Google Health recently partnered with iCAD to improve breast cancer screening with AI.
Leading the Healthcare AI-Space
Both Verily and DeepMind have strategically positioned themselves as trailblazers in AI-led healthcare innovations. Through strategic alliances with esteemed healthcare institutions, they have harnessed colossal datasets to fuel their AI algorithms, resulting in more accurate diagnostics and informed decision-making. This positioning not only propels their R&D endeavors but also solidifies their standing within the medical community.
End To End Integration Game Play – R&D to Sales and CRM
The trajectory from research and development to sales and customer relationship management is a harmonious symphony for Google Verily and DeepMind. Insights gained from their AI-powered solutions seamlessly transition into tangible products and services tailored to the ever-evolving Healthcare industry. This fast track progression from lab concepts to real-world solutions underscores their ability to accelerate tangible real-world impact.
Unveiling the Lucrative Business Potential
The business potential of AI-fueled medical technology is staggering. The global AI in healthcare market is poised to reach unprecedented heights, driven by escalating demand for precise diagnostics, personalized treatments, and predictive analytics. Google Verily and DeepMind are strategically positioned to tap into this market, not just through direct sales but also by collaborating with Healthcare Providers, Medical Devices and Diagnostics and Pharmaceutical giants to forge new paths in medical technology.
The Scientific and Tech Compounding Effect
The scientific and technological effect of Verily and DeepMind’s solutions is profound. These entities are not only advancing comprehension of diseases and treatment trajectories; they are also pioneering novel methodologies that expedite drug discovery and revolutionize clinical trial processes. The convergence of large-scale data analysis, AI-driven predictions, and generative AI tools has the potential to overhaul precision medicine, ushering in an era centered around patient-centric care.
Upcoming Breakthroughs:
In the near future, we anticipate breakthroughs like high degree diagnostic precision for complex diseases, early prediction of patient deterioration, and streamlined drug discovery procedures. Verily’s Project Baseline will continue to unravel invaluable health insights, while DeepMind’s AI-powered predictions will refine patient care protocols. Additionally, both entities are on the brink of launching solutions that incorporate language models and natural language processing (NLP) to revolutionize HIS, electronic health records (EHR) and elevate clinician-patient interactions.
Future Horizons: Endless Possibilities
AI’s potential to forecast disease outbreaks, optimize hospital operations, and tailor treatments to individual genetic profiles is awe-inspiring. The convergence of AI, ML, generative AI tools, and the capabilities of large language models (LLM) holds the key to accelerating medical breakthroughs and cultivating a healthcare ecosystem that prioritizes preventative measures, personalized medication and precision interventions.
Conclusion: A New AI AGE in Healthcare
The recap of Google Verily and DeepMind’s journey into AI-driven healthcare epitomizes innovation. Their fusion of technological advancements with medical solutions bridges gaps, offering accurate diagnoses, personalized treatments, and improved patient care. As we stand on the doors of a healthcare revolution, it’s clear that the integration of AI into medical technology and life sciences is a transformative force, set to unlock a realm of possibilities previously considered out of reach. Alphabet Inc., Google, Verily, DeepMind and other Google projects are going to play a pivotal role in Ai Lead Healthcare market in next decade.
Alphabet Inc & Google’s recent AI journey and AI lead medical and life sciences investments and current work in progress, are poised to transform the industry in the coming years.
For detailed review, market research, data driven insights and an in depth analysis report on AI and Google/ Big Tech playbook in Gen AI, kindly reach out to us at knowlabs@coin-medix.com. Coin Medix provides you with detailed analysis customized as per your requirements and specifications.
Disclaimer: As a team propagating “use of AI tech for good” and accelerating innovations, we use AI tools to process and research on content.